Mother’s Age | Gestational Age (wks) | Chemotherapy Regimen | Fetal Outcome | Maternal Outcome | |
At diagnosis | At delivery | ||||
27 | 7 | Termination of pregnancy | Planed for ATRA, then Termination of pregnancy, ATRA plus idarubicin | Termination of pregnancy | CR |
23 | 26 | 27 | ATRA 45 mg/m2/day | Death | CR |
40 | 26 | 30 | TRA 45 mg/m2/twice day, idarubicin 12 mg/m2/every other day | A healthy baby | CR |
30 | 34 | 35 | Not treated during pregnancy, After pregnancy ATO + ATRA | 2450 g Preterm healthy | CR |
30 | 23+3 | 30 | ATRA 80 mg/day, Idarubicin (20 mg/day) was concomitantly administered on days 2, 4, and 5 | Fetal death (Hemorrhage) | CR |
41 | 24+4 | 35 | ATRA 45 mg/m2/day | 2950 g preterm healthy baby | CR |
two woman 241st 272nd | 241st 342nd | 251st 362nd | ATRA 45 mg/m2/day | Death1st A healthy 3200 g female infant2nd | Death1st CR2nd |
23 | 26 | 26 | ATRA 45 mg/m2/twice | Death | CR |